Literature DB >> 17605603

Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats.

Jacob A Johnson1, Sheilah A Robertson, Bruno H Pypendop.   

Abstract

OBJECTIVE: To characterize the antinociceptive action of IM-administered butorphanol, buprenorphine, or a combination of both by use of a thermal threshold method in cats. ANIMALS: 2 male and 4 female domestic cats. PROCEDURES: In a controlled, masked, randomized, crossover study design, thermal thresholds were measured by use of a thermal threshold-testing device developed for cats. Each cat received 4 treatments 1 week apart, consisting of 2 simultaneous IM injections in a random order (butorphanol-saline [0.9% NaCl] solution, buprenorphine-saline solution, butorphanol-buprenorphine, and saline solution-saline solution). The tester was unaware of the treatment given. Thermal thresholds were measured prior to injection, at intervals up to 12 hours, and at 22 hours after injection.
RESULTS: There was no significant change in threshold over time after saline solution administration. All 3 opioid treatment groups had significant increases in thermal threshold, compared with pretreatment values (butorphanol, from 50 minutes to 8 hours; buprenorphine, from 35 minutes to 5 hours; and butorphanol-buprenorphine, from 50 minutes to 8 hours). Thermal thresholds did not differ significantly among opioid treatments at any time points, and thermal thesholds of only 2 opioid treatments (butorphanol at 50 minutes and butorphanol-buprenorphine at 8 hours) were significantly different from that of saline solution. CONCLUSIONS AND CLINICAL RELEVANCE: All 3 opioid treatments provided similar antinociception, although there was considerable intercat variability in the response to the different opioid treatments. This emphasizes the importance of assessing each patient individually and applying the treatment that works best for that patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605603     DOI: 10.2460/ajvr.68.7.699

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  Thermal threshold testing for evaluation of analgesics in New Zealand white rabbits.

Authors:  Linda S Barter; Anna Kwiatkowski
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

Review 2.  A review of the studies using buprenorphine in cats.

Authors:  P V M Steagall; B P Monteiro-Steagall; P M Taylor
Journal:  J Vet Intern Med       Date:  2014-03-21       Impact factor: 3.333

3.  Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.

Authors:  Graeme M Doodnaught; Beatriz P Monteiro; Javier Benito; Daniel Edge; Francis Beaudry; Ludovic Pelligand; Paulo Steagall
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

4.  A Pilot Study of Cancer-Induced Bone Pain Using Validated Owner Questionnaires, Serum N-Telopeptide Concentration, Kinetic Analysis, and PET/CT.

Authors:  Brian K Flesner; Bryan T Torres; Kyle D Hutcheson; Hansjörg Rindt; Amy R Zalcman; Charles A Maitz
Journal:  Front Vet Sci       Date:  2021-12-16

5.  Antinociceptive effects of the combined use of butorphanol and buprenorphine in mice.

Authors:  Kazumasu Sasaki; Tatsuya Ishikawa; Kazutaka Ikeda; Shinya Kasai
Journal:  Neuropsychopharmacol Rep       Date:  2021-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.